Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Lyon-based biotech specializing in vaccines continues to decline during the session, in an otherwise well-oriented SBF 120. The stock is sinking i…
The Lyon-based biotech specializing in vaccines declines during the session, amidst a slightly bullish SBF 120. The stock continues to operate in a fr…
Valneva Laboratories announced on Thursday its participation in several investor conferences in June 2026 in the United States and Europe. The managem…
Valneva laboratory regains momentum in the late afternoon, in a rising Parisian market. The stock erases some of its recent slide, after weeks marked …
The stock of the vaccine-specialized lab continues to decline this Wednesday at midday. Valneva is down 1.96% at €2.3980, while the SBF 120 index is u…
Valneva has released its Q1 2026 results, showing a 37% decrease in revenue and a net loss of €32.1 million, compared to a €9.2 million loss in Q1 202…
The stock of the Nantes-based vaccine specialist fell sharply this Tuesday morning to €2.63. Valneva is among the top 5 biggest losers in the SBF 120,…
Valneva, a vaccine-specialized laboratory, records the highest rebound in the SBF 120 on Monday midday, climbing to €2.68, while the broader index dro…
The stock of the Nantes-based vaccine specialist continues to decline mid-morning this Friday, May 8, as the CAC 40 drops 0.83% during the session. Va…
The stock of the Nantes-based vaccine specialist continues its slide this Tuesday, May 5th. Valneva is down by 2.62% at €2.196 in mid-morning trading,…
